Selfapy is pioneering mental health solutions with its unique offering—being the first digital self-help tool prescribed for treating depression and anxiety. Founded in 2016, this German startup is making psychological support accessible to everyone, reflected in its slogan, "Selfapy macht psychologische Unterstützung für jede*n möglich."
Operating at the intersection of Health Care, Health and Wellness, Medical Devices, and Sports industries, Selfapy capitalizes on the growing demand for mental health solutions. The company's innovative approach has garnered attention from notable investors including IBB Ventures, Think.Health, The SHS Group, Medice Arzneimittel, and HTGF | High-Tech Gruenderfonds, culminating in a €7.00M Venture Round on 17 February 2023.
With its headquarters in Germany, Selfapy is strategically positioned to expand its impact within Europe and beyond, offering a compelling investment opportunity in the rapidly evolving digital health space.